Howard Dean isn't toeing the party line when it comes to the Affordable Care Act, Newser reports. In a Wall Street Journal op-ed, Dean praises parts of the law, but takes aim at one of its key provisions: "the so-called Independent Payment Advisory Board," that will determine what rates Medicare will pay for various procedures and drugs. "The IPAB will be able to stop certain treatments its members do not favor by simply setting rates to levels where no doctor or hospital will perform them," Dean warns. More here. [BJS]
